Sandra Patterson

After 30 years, Straine consolidates its consulting, analytics, and management arms, a strategic move to clarify its integrated model in a competitive market.

Energy giant Sempra posts strong Q1 earnings and affirms a massive $65 billion investment plan to overhaul the energy grids of Texas and California.

REIT giant Macerich acquires Annapolis Mall, planning a major overhaul with tenants like Tesla and Dick's House of Sport to dominate the D.C. retail market.

The child care giant was named a Best Place to Work. We explore the deep investment in its workforce that fuels its success and offers lessons for others.

With a key FDA decision looming, Cristcot hires Rayna Herman to lead the commercial strategy for its first-in-class ulcerative colitis therapy, ngHCA.

Amble Health's new program offers 50% off weight loss drugs, but it requires patients to pay cash and potentially use non-FDA-approved medications.

An AI procurement firm has joined the council that sets government purchasing standards. Can it solve bureaucracy or will it create new digital gatekeepers?

As firms struggle with AI ROI, Allego's new platform embeds practical intelligence into daily workflows, aiming to bridge the gap between hype and results.

CTIBIOTECH brings revolutionary 3D human tissue printing to 'Cellicon Valley,' aiming to slash drug failures and accelerate personalized medicine.

The sports retailer has relocated its Topeka store to a massive 12,000 sq. ft. space, signaling a major investment in the local retail economy.

Beyond the ABCs, Sesame Workshop is expanding its global initiative to equip children and families with crucial tools for emotional well-being.

With its new P1 Series robot, Dreame is taking on the multi-billion dollar window cleaning industry by tackling the toughest stains and missed corners.

Sustainable materials firm Origin Materials announces its shutdown, a stark end for a once-promising SPAC darling and a warning for the green tech industry.

Forbright Bank buys its Chevy Chase HQ, partnering with R3 Ventures to modernize the tower and navigate a challenging D.C. office market.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

A tiny brush, engineered to micron-level precision, is at the forefront of a high-tech shift in medical manufacturing, enabling the future of robotics and AI.

Celebrating five decades of growth, Montreal's NATIONAL Public Relations has become a global powerhouse. A look at AVENIR GLOBAL's past, present, and future.

Facing a steep revenue drop, High Arctic banks on a new contract, diversification into rentals and fire services, and the promise of PNG's massive LNG project.

Ottawa's new economic update promises relief from high costs and a crackdown on fraud, but critics question the price tag and long-term strategy.